Overexpressed cell surface interleukin-4 receptor molecules can be successfully targeted for antitumor cytotoxin therapy. [electronic resource]
- Critical reviews in immunology 2001
- 299-310 p. digital
Publication Type: Journal Article; Review
1040-8401
Animals Brain Neoplasms--therapy Clinical Trials, Phase I as Topic Humans Immunotoxins--pharmacokinetics Interleukin-4 Receptors, Interleukin-4--biosynthesis Tissue Distribution